Dealing in securities by Directors and by Directors of major subsidiaries ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 ("Aspen" or "the Company") DEALING IN SECURITIES BY DIRECTORS AND BY DIRECTORS OF A MAJOR SUBSIDIARY In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: Deferred bonus shares have vested in respect of the Aspen South African Management Deferred Incentive Scheme as accepted by directors of the Company and directors of a major subsidiary of the Company in 2010 and which they continue to hold. BY DIRECTORS OF THE COMPANY: Director : Michael Guy Attridge Company : Aspen Pharmacare Holdings Limited Date of transaction : 18 November 2013 Number of shares sold to pay tax : 8 359 Value of shares sold on market : R2 229 596.07 Selling price : R266.73 Shares retained : 11 231 Value of shares retained : R2 995 644.63 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes BY DIRECTORS OF THE COMPANY: Director : Stephen Bradley Saad Company : Aspen Pharmacare Holdings Limited Date of transaction : 18 November 2013 Shares delivered : 23 698 Value of shares delivered : R6 320 967.54 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes BY DIRECTORS OF A MAJOR SUBSIDIARY: Director : Sean Matthew Capazorio Company : Pharmacare Limited Date of transaction : 18 November 2013 Number of shares sold to pay tax : 3 262 Value of shares sold on market : R870 073.26 Selling price : R266.73 Shares retained : 4 382 Value of shares retained : R1 168 810.86 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes Director : Mziwandile Noel Guliwe Company : Pharmacare Limited Date of transaction : 18 November 2013 Number of shares sold to pay tax : 4 300 Value of shares sold on market : R1 146 939.00 Selling price : R266.73 Shares retained : 6 014 Value of shares retained : 1 604 114.22 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes Director : Morne Geyser Company : Pharmacare Limited Date of transaction : 18 November 2013 Number of shares sold to pay tax : 2 564 Value of shares sold on market : R683 895.72 Selling price : R266.73 Shares retained : 3 586 Value of shares retained : R956 493.78 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes Durban 19 November 2013 Sponsor Investec Bank Limited Date: 19/11/2013 04:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.